CLINICAL_TRIALS
trial_result
· 2025-01-15
Clinical Trial Update: Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD) [Phase 2]
Summary
A Phase 2 study evaluating the efficacy and safety of NBI-1065845 in adults with major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocrine Biosciences | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED